Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Diemert

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Scientific Reports|February 22, 2023
Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairsKaitlin Garofano, Kameron Rashid, Michael Smith, et al.
Plos Neglected Tropical Diseases|February 14, 2017
Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccineJill B Brelsford, Jordan L Plieskatt, Anna Yakovleva, et al.
Plos One|September 26, 2022
Investigation of urinary metabolomics in a phase I hookworm vaccine trial in GabonMadeleine Eunice Betouke Ongwe, Yoanne D Mouwenda, Koen A Stam, et al.
Vaccine|April 20, 2013
The Human Hookworm VaccinePeter J Hotez, David Diemert, Kristina M Bacon, et al.
Vaccine|November 26, 2024
Vaccine value profile for schistosomiasisGavin Yamey, Kaci Kennedy McDade, Roy M Anderson, et al.
STAR Protocols|September 21, 2023
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humansLarissa L S Scholte, David J Leggat, Kristen W Cohen, et al.
Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.
The New England Journal of Medicine|December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 22, 2023
Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairsKaitlin Garofano, Kameron Rashid, Michael Smith, et al.
Plos Neglected Tropical Diseases|February 14, 2017
Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccineJill B Brelsford, Jordan L Plieskatt, Anna Yakovleva, et al.
Plos One|September 26, 2022
Investigation of urinary metabolomics in a phase I hookworm vaccine trial in GabonMadeleine Eunice Betouke Ongwe, Yoanne D Mouwenda, Koen A Stam, et al.
Vaccine|April 20, 2013
The Human Hookworm VaccinePeter J Hotez, David Diemert, Kristina M Bacon, et al.
Vaccine|November 26, 2024
Vaccine value profile for schistosomiasisGavin Yamey, Kaci Kennedy McDade, Roy M Anderson, et al.
STAR Protocols|September 21, 2023
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humansLarissa L S Scholte, David J Leggat, Kristen W Cohen, et al.
Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.
The New England Journal of Medicine|December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Pageof 4